COVID Clinical Trials in Boston, Massachusetts
12 recruitingBoston, Massachusetts
Showing 1–12 of 12 trials
Recruiting
Phase 3
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Pfizer300 enrolled132 locationsNCT07013474
Recruiting
Phase 3
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Long COVID
Wes Ely550 enrolled16 locationsNCT06631287
Recruiting
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
CancerAtrial FibrillationThrombosis+1 more
Massachusetts General Hospital165 enrolled1 locationNCT03830320
Recruiting
Not Applicable
Mind Body Intervention for Long COVID-19
Long COVID
Beth Israel Deaconess Medical Center180 enrolled1 locationNCT06045338
Recruiting
Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
COVID-19Influenza
Boston University10,000 enrolled2 locationsNCT06168019
Recruiting
Not Applicable
Sauna for Long Covid
Long COVID
Massachusetts General Hospital21 enrolled1 locationNCT05931497
Recruiting
Phase 2
LIFT: Life Improvement Trial
ME/CFSLong COVIDPASC
Brigham and Women's Hospital160 enrolled1 locationNCT06366724
Recruiting
Phase 2
AT1001 for the Treatment of Long COVID
Long COVID
Massachusetts General Hospital150 enrolled2 locationsNCT05747534
Recruiting
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
Post COVID-19 ConditionDyspneaPost-Acute COVID-19+1 more
Tufts Medical Center40 enrolled1 locationNCT05866952
Recruiting
Phase 3
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
COVID-19
Pfizer160 enrolled73 locationsNCT05261139
Recruiting
Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
COVID-19Lower Respiratory Tract InfectionImmunocompromised+1 more
Ansun Biopharma, Inc.274 enrolled67 locationsNCT03808922